DEA States New Rules for Synthetic Cannabinoids

[ad_1] The Drug Enforcement Administration (DEA) recently announced at the 2023 Supply Chain Conference in Houston, Texas that it will soon unveil new rules regarding synthetic cannabinoids. The DEA’s Section Chief of Drug and Chemical Evaluation Section, Terrance Boos, spoke on the topic of emerging trends at the conference on May 4. Boos confirmed that the DEA has received “multiple petitions” regarding synthetic cannabinoids, and that they’re currently reworking their rules to reflect recommendations from…

"DEA States New Rules for Synthetic Cannabinoids"

The Risky Business of Synthetic Highs

[ad_1] A cannabinoid is any molecule that interacts with at least one of the body’s two cannabinoid receptors, CB1 and CB2. This large class of chemicals can be divided into three parts: those produced by cannabis, called phytocannabinoids; those produced within the body, called endogenous cannabinoids or endocannabinoids; and those produced in a lab (that don’t also exist in nature), called synthetic cannabinoids. It’s this latter class of novel molecules, encompassing valuable research chemicals and…

"The Risky Business of Synthetic Highs"